Jidong Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jidong Wang has a total of 89 co-authors. Here are the top co-authors by number of shared publications:
- Jian Li
Hebei Key Laboratory of Applied Chemistry, Hebei Key Laboratory of Nanobiotechnology, Hebei Key Laboratory of Heavy Metal Deep-Remediation in Water and Resource Reuse, Yanshan University, Qinhuangdao, 066004, China
9 shared publications Kun Li
Yanshan University, Hebei Street No. 438, Qinhuangdao, Hebei Province, 066004, CHINA
6 shared publicationsLiming Gao
The First Hospital in Qinhuangdao
6 shared publications- Hong Jiang
State Key Laboratory of Metastable Materials Science and Technology, Nano-biotechnology Key Lab of Hebei Province, Yanshan University, Qinhuangdao, 066004, China
5 shared publications Ming Shi
Yanshan University, Hebei Street No. 438, Qinhuangdao, Hebei Province, 066004, CHINA
5 shared publicationsZhiwei Liu
Yanshan University, No. 438, West Section of Hebei Street, Qinhuangdao, Hebei, 066004, CHINA
5 shared publications
Latest Publications
- 5 June 2025
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 97 (23) , 12364-12371
Light-Addressable Regenerative Photoelectrochemical Biosensor Array with Self-Calibration for High-Throughput and Accurate Detection of Circulating Tumor Cells
High-efficiency detection of circulating tumor cells (CTCs) provides real-time information for cancer diagnosis and therapy. The light-addressable photoelectrochemical biosensor array (LAPECBA) is the best candidate for rapid and high-throughput detection. However, strong background interference, baseline drift, and batch deviation hinder the further application of LAPECBA. Here, we reported a LAPECBA with self-calibration for high-throughput and accurate detection of CTCs. The α-Fe2O3/Bi2S3 heterojunction was synthesized as an electrode substrate material to enhance the photoelectric performance, and the aptamer-DNA concatemer (ADC) interface was constructed for high-efficiency capture of CTCs and release the CTCs with the assistance of ATP. Light-addressable multiplexed detection was achieved by constructing multiple regions on a single FTO electrode and sequentially exposing them with a laser pen. A self-calibration strategy was implemented by calculating the photocurrent differences between the detection channels and calibration channel to diminish the strong background interference, baseline drift, and batch deviation. Under optimal conditions, this LAPECBA could detect CTCs in the linear range of 50-1000 cells mL-1 with a detection limit of 2 cells mL-1 (S/N = 3). Additionally, the trapped CTCs were released by ATP-stimulated ADC disintegration, benefiting downstream analysis and demonstrating the high regenerative potential of LAPECBA. This self-calibrating LAPECBA exhibited great potential for accurate and high-throughput detection of CTCs in clinics.
- 5 June 2025
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 97 (23) , 12364-12371
Light-Addressable Regenerative Photoelectrochemical Biosensor Array with Self-Calibration for High-Throughput and Accurate Detection of Circulating Tumor Cells
High-efficiency detection of circulating tumor cells (CTCs) provides real-time information for cancer diagnosis and therapy. The light-addressable photoelectrochemical biosensor array (LAPECBA) is the best candidate for rapid and high-throughput detection. However, strong background interference, baseline drift, and batch deviation hinder the further application of LAPECBA. Here, we reported a LAPECBA with self-calibration for high-throughput and accurate detection of CTCs. The α-Fe2O3/Bi2S3 heterojunction was synthesized as an electrode substrate material to enhance the photoelectric performance, and the aptamer-DNA concatemer (ADC) interface was constructed for high-efficiency capture of CTCs and release the CTCs with the assistance of ATP. Light-addressable multiplexed detection was achieved by constructing multiple regions on a single FTO electrode and sequentially exposing them with a laser pen. A self-calibration strategy was implemented by calculating the photocurrent differences between the detection channels and calibration channel to diminish the strong background interference, baseline drift, and batch deviation. Under optimal conditions, this LAPECBA could detect CTCs in the linear range of 50-1000 cells mL-1 with a detection limit of 2 cells mL-1 (S/N = 3). Additionally, the trapped CTCs were released by ATP-stimulated ADC disintegration, benefiting downstream analysis and demonstrating the high regenerative potential of LAPECBA. This self-calibrating LAPECBA exhibited great potential for accurate and high-throughput detection of CTCs in clinics.
- 10 May 2024
- Published by IOP Publishing in Biomedical Materials
- Vol. 19 (4) , 045004
Progressive enhanced photodynamic therapy and enhanced chemotherapy fighting against malignant tumors with sequential drug release
During the process of malignant tumor treatment, photodynamic therapy (PDT) exerts poor efficacy due to the hypoxic environment of the tumor cells, and long-time chemotherapy reduces the sensitivity of tumor cells to chemotherapy drugs due to the presence of drug-resistant proteins on the cell membranes for drug outward transportation. Therefore, we reported a nano platform based on mesoporous silica coated with polydopamine (MSN@PDA) loading PDT enhancer MnO2, photosensitizer indocyanine green (ICG) and chemotherapeutic drug doxorubicin (DOX) (designated as DMPIM) to achieve a sequential release of different drugs to enhance treatment of malignant tumors. MSN was first synthesized by a template method, then DOX was loaded into the mesoporous channels of MSN, and locked by the PDA coating. Next, ICG was modified by π–π stacking on PDA, and finally, MnO2 layer was accumulated on the surface of DOX@MSN@PDA- ICG@MnO2, achieving orthogonal loading and sequential release of different drugs. DMPIM first generated oxygen (O2) through the reaction between MnO2 and H2O2 after entering tumor cells, alleviating the hypoxic environment of tumors and enhancing the PDT effect of sequentially released ICG. Afterwards, ICG reacted with O2 in tumor tissue to produce reactive oxygen species, promoting lysosomal escape of drugs and inactivation of p-glycoprotein (p-gp) on tumor cell membranes. DOX loaded in the MSN channels exhibited a delay of approximately 8 h after ICG release to exert the enhanced chemotherapy effect. The drug delivery system achieved effective sequential release and multimodal combination therapy, which achieved ideal therapeutic effects on malignant tumors. This work offers a route to a sequential drug release for advancing the treatment of malignant tumors.
- 10 May 2024
- Published by IOP Publishing in Biomedical Materials
- Vol. 19 (4) , 045004
Progressive enhanced photodynamic therapy and enhanced chemotherapy fighting against malignant tumors with sequential drug release
During the process of malignant tumor treatment, photodynamic therapy (PDT) exerts poor efficacy due to the hypoxic environment of the tumor cells, and long-time chemotherapy reduces the sensitivity of tumor cells to chemotherapy drugs due to the presence of drug-resistant proteins on the cell membranes for drug outward transportation. Therefore, we reported a nano platform based on mesoporous silica coated with polydopamine (MSN@PDA) loading PDT enhancer MnO2, photosensitizer indocyanine green (ICG) and chemotherapeutic drug doxorubicin (DOX) (designated as DMPIM) to achieve a sequential release of different drugs to enhance treatment of malignant tumors. MSN was first synthesized by a template method, then DOX was loaded into the mesoporous channels of MSN, and locked by the PDA coating. Next, ICG was modified by π–π stacking on PDA, and finally, MnO2 layer was accumulated on the surface of DOX@MSN@PDA- ICG@MnO2, achieving orthogonal loading and sequential release of different drugs. DMPIM first generated oxygen (O2) through the reaction between MnO2 and H2O2 after entering tumor cells, alleviating the hypoxic environment of tumors and enhancing the PDT effect of sequentially released ICG. Afterwards, ICG reacted with O2 in tumor tissue to produce reactive oxygen species, promoting lysosomal escape of drugs and inactivation of p-glycoprotein (p-gp) on tumor cell membranes. DOX loaded in the MSN channels exhibited a delay of approximately 8 h after ICG release to exert the enhanced chemotherapy effect. The drug delivery system achieved effective sequential release and multimodal combination therapy, which achieved ideal therapeutic effects on malignant tumors. This work offers a route to a sequential drug release for advancing the treatment of malignant tumors.
- 7 February 2024
- Published by IOP Publishing in Biofabrication
- Vol. 16 (2) , 025012
Multilayer nanodrug delivery system with spatiotemporal drug release improves tumor microenvironment for synergistic anticancer therapy
The inflammatory response is one of the general symptoms that accompany tumorigenesis, the pro-inflammatory factors cyclooxygenase-2 (COX-2) and COX-2-derived prostaglandin-2 (PGE-2) in the inflammatory environment surrounding tumors possess promoting tumor development, metastasis and angiogenesis effects. In addition, the hypoxic environment of tumors severely limits the effectiveness of photodynamic therapy (PDT). In this study, a universal extracellular-intracellular ‘on-demand’ release nanomedicine DOX@PDA-ICG@MnO2@GN-CEL was developed for the combined fight against malignant tumors using a spatiotemporal controlled gelatin coated polydopamine (PDA@GN) as the carrier and loaded with the chemotherapeutic drug doxorubicin (DOX), the photosensitizer indocyanine green (ICG), the PDT enhancer MnO2 and the anti-inflammatory drug celecoxib (CEL) individually. Our results showed that DOX@PDA-ICG@MnO2@GN-CEL could release CEL extracellularly by matrix metalloproteinase-2 response and inhibit the COX-2/PGE-2 pathway, reduce chemotherapy resistance and attenuate the concurrent inflammation. After entering the tumor cells, the remaining DOX@PDA-ICG@MnO2 released DOX, ICG and MnO2 intracellularly through PDA acid response. MnO2 promoted the degradation of endogenous H2O2 to generate oxygen under acidic conditions to alleviate the tumor hypoxic environment, enhance PDT triggered by ICG. PDA and ICG exhibited photothermal therapy synergistically, and DOX exerted chemotherapy with reduced chemotherapy resistance. The dual responsive drug release switch enabled the chemotherapeutic, photothermal, photodynamic and anti-inflammatory drugs precisely acted on different sites of tumor tissues and realized a promising multimodal combination therapy.
- 7 February 2024
- Published by IOP Publishing in Biofabrication
- Vol. 16 (2) , 025012
Multilayer nanodrug delivery system with spatiotemporal drug release improves tumor microenvironment for synergistic anticancer therapy
The inflammatory response is one of the general symptoms that accompany tumorigenesis, the pro-inflammatory factors cyclooxygenase-2 (COX-2) and COX-2-derived prostaglandin-2 (PGE-2) in the inflammatory environment surrounding tumors possess promoting tumor development, metastasis and angiogenesis effects. In addition, the hypoxic environment of tumors severely limits the effectiveness of photodynamic therapy (PDT). In this study, a universal extracellular-intracellular ‘on-demand’ release nanomedicine DOX@PDA-ICG@MnO2@GN-CEL was developed for the combined fight against malignant tumors using a spatiotemporal controlled gelatin coated polydopamine (PDA@GN) as the carrier and loaded with the chemotherapeutic drug doxorubicin (DOX), the photosensitizer indocyanine green (ICG), the PDT enhancer MnO2 and the anti-inflammatory drug celecoxib (CEL) individually. Our results showed that DOX@PDA-ICG@MnO2@GN-CEL could release CEL extracellularly by matrix metalloproteinase-2 response and inhibit the COX-2/PGE-2 pathway, reduce chemotherapy resistance and attenuate the concurrent inflammation. After entering the tumor cells, the remaining DOX@PDA-ICG@MnO2 released DOX, ICG and MnO2 intracellularly through PDA acid response. MnO2 promoted the degradation of endogenous H2O2 to generate oxygen under acidic conditions to alleviate the tumor hypoxic environment, enhance PDT triggered by ICG. PDA and ICG exhibited photothermal therapy synergistically, and DOX exerted chemotherapy with reduced chemotherapy resistance. The dual responsive drug release switch enabled the chemotherapeutic, photothermal, photodynamic and anti-inflammatory drugs precisely acted on different sites of tumor tissues and realized a promising multimodal combination therapy.
- 5 February 2024
- Published by IOP Publishing in Biomedical Materials
- Vol. 19 (2) , 025024
Nanoparticles loaded with β-Lapachone and Fe3+ exhibit enhanced chemodynamic therapy by producing H2O2 through cascaded amplification
The rapid, irreversible change of active Fe2+ to inactive Fe3+ after the Fenton reaction occurring reduces the chemodynamic therapeutic (CDT) effect. Therefore, manipulation of the tumor microenvironment to provide sufficient hydrogen peroxide (H2O2) while maintaining metal ion catalyst activity is critical for effective CDT. Here, β-Lapachone (LPC) was loaded by mesoporous silica nanoparticles (MSNs) and coated with polydopamine (PDA) to further chelate Fe3+ and link aptamer AS1411, and a pH-controlled released, chemotherapy-photothermal therapy (PTT)-enhanced CDT-small molecule therapy combination drug delivery system with passive and active tumor targeting was engineered (designated as β-LPC@MSN@PDA/Fe3+-AS1411, LMPFA). The results showed that LFMPA nanoparticles massively accumulated in tumor tissues to achieve tumor targeting through AS1411 mediating and enhanced permeability and retention (EPR) effect. Subsequently, PDA released Fe3+ and LPC through acid response to exhibited CDT and chemotherapeutic therapy. Meanwhile, the photothermal effect of PDA promoted the release of LPC from the pores of MSN. LPC exerted chemotherapy effect and cyclically producing of H2O2 by the catalysis of NQO1, which enhanced the CDT activated by Fe3+. In addition, while serving as a targeted ligand, AS1411 could also exhibit a small molecule therapeutic effect by binding to nucleoli of tumor cells. This unique nano delivery system achieved the combination of chemotherapy, PTT, enhanced CDT and small molecule therapy, and fought against malignant tumors synergistically through multi-target and multi-dimension.
- 5 February 2024
- Published by IOP Publishing in Biomedical Materials
- Vol. 19 (2) , 025024
Nanoparticles loaded with β-Lapachone and Fe3+ exhibit enhanced chemodynamic therapy by producing H2O2 through cascaded amplification
The rapid, irreversible change of active Fe2+ to inactive Fe3+ after the Fenton reaction occurring reduces the chemodynamic therapeutic (CDT) effect. Therefore, manipulation of the tumor microenvironment to provide sufficient hydrogen peroxide (H2O2) while maintaining metal ion catalyst activity is critical for effective CDT. Here, β-Lapachone (LPC) was loaded by mesoporous silica nanoparticles (MSNs) and coated with polydopamine (PDA) to further chelate Fe3+ and link aptamer AS1411, and a pH-controlled released, chemotherapy-photothermal therapy (PTT)-enhanced CDT-small molecule therapy combination drug delivery system with passive and active tumor targeting was engineered (designated as β-LPC@MSN@PDA/Fe3+-AS1411, LMPFA). The results showed that LFMPA nanoparticles massively accumulated in tumor tissues to achieve tumor targeting through AS1411 mediating and enhanced permeability and retention (EPR) effect. Subsequently, PDA released Fe3+ and LPC through acid response to exhibited CDT and chemotherapeutic therapy. Meanwhile, the photothermal effect of PDA promoted the release of LPC from the pores of MSN. LPC exerted chemotherapy effect and cyclically producing of H2O2 by the catalysis of NQO1, which enhanced the CDT activated by Fe3+. In addition, while serving as a targeted ligand, AS1411 could also exhibit a small molecule therapeutic effect by binding to nucleoli of tumor cells. This unique nano delivery system achieved the combination of chemotherapy, PTT, enhanced CDT and small molecule therapy, and fought against malignant tumors synergistically through multi-target and multi-dimension.
- 24 January 2024
- Published by Royal Society of Chemistry (RSC) in Biomaterials Science
- Vol. 12 (6) , 1529-1535
A photoelectrochemical cytosensor based on a Bi2S3–MoS2 heterojunction-modified reduced oxide graphene honeycomb film for sensitive detection of circulating tumor cells
A novel photoelectrochemical (PEC) cytosensor for the ultrasensitive detection of circulating tumor cells (CTCs) was developed. The bio-inspired reduced graphene oxide (rGO) honeycomb film photoelectrode was fabricated via a “breath figure” method, followed by the self-assembly of a Bi2S3–MoS2 heterojunction. The resulting Bi2S3–MoS2 heterojunction-modified rGO honeycomb film was employed as a sensing matrix for the first time. Compared to the smooth rGO film, the significant enhanced photocurrent of the photoelectrode under visible light was attributed to its improved visible light absorption, increased surface area and enhanced separation efficiency of photo-generated electron–hole pairs, which met the requirements of the PEC sensor for detecting larger targets. By virtue of the photocurrent decrease due to the steric hindrance of MCF-7 cells, which were captured by an aptamer immobilized on the surface of the photoelectrode, a cytosensor for detecting CTCs was achieved, showing a wide linear range of 10–1 × 105 cells per mL and a low detection limit of 2 cells per mL. Furthermore, MCF-7 cells in human serum were determined by this PEC biosensor, exhibiting great potential in the clinical detection of CTCs.
- 24 January 2024
- Published by Royal Society of Chemistry (RSC) in Biomaterials Science
- Vol. 12 (6) , 1529-1535
A photoelectrochemical cytosensor based on a Bi2S3–MoS2 heterojunction-modified reduced oxide graphene honeycomb film for sensitive detection of circulating tumor cells
A novel photoelectrochemical (PEC) cytosensor for the ultrasensitive detection of circulating tumor cells (CTCs) was developed. The bio-inspired reduced graphene oxide (rGO) honeycomb film photoelectrode was fabricated via a “breath figure” method, followed by the self-assembly of a Bi2S3–MoS2 heterojunction. The resulting Bi2S3–MoS2 heterojunction-modified rGO honeycomb film was employed as a sensing matrix for the first time. Compared to the smooth rGO film, the significant enhanced photocurrent of the photoelectrode under visible light was attributed to its improved visible light absorption, increased surface area and enhanced separation efficiency of photo-generated electron–hole pairs, which met the requirements of the PEC sensor for detecting larger targets. By virtue of the photocurrent decrease due to the steric hindrance of MCF-7 cells, which were captured by an aptamer immobilized on the surface of the photoelectrode, a cytosensor for detecting CTCs was achieved, showing a wide linear range of 10–1 × 105 cells per mL and a low detection limit of 2 cells per mL. Furthermore, MCF-7 cells in human serum were determined by this PEC biosensor, exhibiting great potential in the clinical detection of CTCs.
- 6 November 2023
- Published by Wiley in Rare Metals
- Vol. 43 (1) , 138-147
Superhydrophilic nickel hydroxide ultrathin nanosheets enable high‐performance asymmetric supercapacitors
Superhydrophilic surfaces have been applied for supercapacitor; however, during energy storage reaction, how the wettability affects the process of electrochemical reaction specifically is still unclear. Herein, we demonstrate superhydrophilic surface for promotion of electrochemical reactions by liquid affinity and further explain the mechanism, where the transition of the wettability state caused by the change in surface free energy is the main reason for the obvious increase in specific capacitance. Through citric acid assistance strategy, an intrinsically hydrophobic Ni(OH) 2 thick nanosheets (HNHTNs, 16 nm) can be transitioned into superhydrophilic Ni(OH) 2 ultrathin nanosheets (SNHUNs, 6.8 nm), where the water contact angle was 0° and the surface free energy increased from 8.6 to 65.8 mN·m −1 , implying superhydrophilicity. Compared with HNHTNs, the specific capacitance of SNHUNs is doubled: from 1230 F·g −1 (HNHTNs) to 2350 F·g −1 (2 A·g −1 ) and, even at 20 A·g −1 , from 833 F·g −1 (HNHTNs) to 1670 F·g −1 . The asymmetric capacitors assembled by SNHUNs and activated carbon show 52.44 Wh·kg −1 at 160 W·kg −1 and excellent stability with ~ 90% retention after 5000 cycles (~ 80% retention after 9500 cycles). The promotion of electrochemical performances is ascribed to the change of surface wettability caused by surface free energy, which greatly increase affinity of electrode to the surrounding liquid environment to reduce the interface resistance and optimize the electron transport path.
- 6 November 2023
- Published by Wiley in Rare Metals
- Vol. 43 (1) , 138-147
Superhydrophilic nickel hydroxide ultrathin nanosheets enable high‐performance asymmetric supercapacitors
Superhydrophilic surfaces have been applied for supercapacitor; however, during energy storage reaction, how the wettability affects the process of electrochemical reaction specifically is still unclear. Herein, we demonstrate superhydrophilic surface for promotion of electrochemical reactions by liquid affinity and further explain the mechanism, where the transition of the wettability state caused by the change in surface free energy is the main reason for the obvious increase in specific capacitance. Through citric acid assistance strategy, an intrinsically hydrophobic Ni(OH) 2 thick nanosheets (HNHTNs, 16 nm) can be transitioned into superhydrophilic Ni(OH) 2 ultrathin nanosheets (SNHUNs, 6.8 nm), where the water contact angle was 0° and the surface free energy increased from 8.6 to 65.8 mN·m −1 , implying superhydrophilicity. Compared with HNHTNs, the specific capacitance of SNHUNs is doubled: from 1230 F·g −1 (HNHTNs) to 2350 F·g −1 (2 A·g −1 ) and, even at 20 A·g −1 , from 833 F·g −1 (HNHTNs) to 1670 F·g −1 . The asymmetric capacitors assembled by SNHUNs and activated carbon show 52.44 Wh·kg −1 at 160 W·kg −1 and excellent stability with ~ 90% retention after 5000 cycles (~ 80% retention after 9500 cycles). The promotion of electrochemical performances is ascribed to the change of surface wettability caused by surface free energy, which greatly increase affinity of electrode to the surrounding liquid environment to reduce the interface resistance and optimize the electron transport path.
- 17 July 2023
- Published by IOP Publishing in Biomedical Materials
- Vol. 18 (5) , 055004
Non-interference delivery of Ce6 and DOX in NIR light-responsive liposomes for synergetic cervical cancer therapy
Multi-model combination treatment of malignant tumors can make up for the shortcomings of single treatment through multi-target and multi-path to achieve more ideal tumor treatment effect. However, the mutual interference of different drugs in the delivery process in vivo and the difficulty of effective drug accumulation in tumor cells are the bottlenecks of combined therapy. To this project, light-responsive liposomes loading doxorubicin (DOX) and chlorin e6 (Ce6) (DOX-Ce6-Lip) without mutual interference were engineered by thin film hydration method. This kind of nano-drug delivery system increased the drugs concentration accumulated in tumor sites through enhanced permeability and retention effect, and reduced the toxic and side effects of drugs on normal tissues in vivo. In addition, after entering the tumor cells, Ce6 produced a large number of reactive oxygen species under 660 nm NIR laser irradiation, which further oxidized the unsaturated fatty acid chain in the liposomes and caused the collapse of the liposomes, thus realizing the stimulus-responsive release of Ce6 and DOX. The concentrations of DOX and Ce6 in the tumor cells rapidly reached the peak and achieved a more effective combination of chemotherapy and photodynamic therapy (PDT). Consequently, DOX-Ce6-Lip followed by 660 nm NIR irradiation achieved an efficient tumor growth inhibition of 71.90 ± 3.14%, indicating the versatile potential of chemotherapy and PDT. In conclusion, this study provides a delivery scheme for drugs with different solubilities and an effectively combined anti-tumor therapy method.
- 17 July 2023
- Published by IOP Publishing in Biomedical Materials
- Vol. 18 (5) , 055004
Non-interference delivery of Ce6 and DOX in NIR light-responsive liposomes for synergetic cervical cancer therapy
Multi-model combination treatment of malignant tumors can make up for the shortcomings of single treatment through multi-target and multi-path to achieve more ideal tumor treatment effect. However, the mutual interference of different drugs in the delivery process in vivo and the difficulty of effective drug accumulation in tumor cells are the bottlenecks of combined therapy. To this project, light-responsive liposomes loading doxorubicin (DOX) and chlorin e6 (Ce6) (DOX-Ce6-Lip) without mutual interference were engineered by thin film hydration method. This kind of nano-drug delivery system increased the drugs concentration accumulated in tumor sites through enhanced permeability and retention effect, and reduced the toxic and side effects of drugs on normal tissues in vivo. In addition, after entering the tumor cells, Ce6 produced a large number of reactive oxygen species under 660 nm NIR laser irradiation, which further oxidized the unsaturated fatty acid chain in the liposomes and caused the collapse of the liposomes, thus realizing the stimulus-responsive release of Ce6 and DOX. The concentrations of DOX and Ce6 in the tumor cells rapidly reached the peak and achieved a more effective combination of chemotherapy and photodynamic therapy (PDT). Consequently, DOX-Ce6-Lip followed by 660 nm NIR irradiation achieved an efficient tumor growth inhibition of 71.90 ± 3.14%, indicating the versatile potential of chemotherapy and PDT. In conclusion, this study provides a delivery scheme for drugs with different solubilities and an effectively combined anti-tumor therapy method.
- 15 May 2023
- Published by Springer Nature in Microchimica Acta
- Vol. 190 (6) , 1-8
CdSe@CdS quantum dot–sensitized Au/α-Fe2O3 structure for photoelectrochemical detection of circulating tumor cells
Circulating tumor cells (CTCs) are the important biomarker for cancer diagnosis and individualized treatment. However, due to the extreme rarity of CTCs (only 1–10 CTCs are found in every milliliter of peripheral blood) high sensitivity and selectivity are urgently needed for CTC detection. Here, a sandwich PEC cytosensor for the ultrasensitive detection of CTCs was developed using the photoactive material Au NP/-Fe2O3 and core-shell CdSe@CdS QD sensitizer. In the proposed protocol, the CdSe@CdS QD/Au NP/α-Fe2O3-sensitized structure with cascade band-edge levels could evidently promote the photoelectric conversion efficiency due to suitable light absorption and efficient electron-hole pair recombination inhibition. Additionally, a dendritic aptamer-DNA concatemer was constructed for highly efficient capture of MCF-7 cells carrying CdSe@CdS QDs, a sensitive material. The linear range of this proposed signal-on PEC sensing method was 300 cell mL−1 to 6 × 105 cell mL−1 with a detection limit of 3 cell mL−1, and it demonstrated an ultrasensitive response to CTCs. Furthermore, this PEC sensor enabled accurate detection of CTCs in serum samples. Hence, a promising strategy for CTC detection in clinical diagnosis was developed based on CdSe@CdS QD–sensitized Au NP/α-Fe2O3-based PEC cytosensor with dendritic aptamer-DNA concatemer. Graphical abstract
- 15 May 2023
- Published by Springer Nature in Microchimica Acta
- Vol. 190 (6) , 1-8
CdSe@CdS quantum dot–sensitized Au/α-Fe2O3 structure for photoelectrochemical detection of circulating tumor cells
Circulating tumor cells (CTCs) are the important biomarker for cancer diagnosis and individualized treatment. However, due to the extreme rarity of CTCs (only 1–10 CTCs are found in every milliliter of peripheral blood) high sensitivity and selectivity are urgently needed for CTC detection. Here, a sandwich PEC cytosensor for the ultrasensitive detection of CTCs was developed using the photoactive material Au NP/-Fe2O3 and core-shell CdSe@CdS QD sensitizer. In the proposed protocol, the CdSe@CdS QD/Au NP/α-Fe2O3-sensitized structure with cascade band-edge levels could evidently promote the photoelectric conversion efficiency due to suitable light absorption and efficient electron-hole pair recombination inhibition. Additionally, a dendritic aptamer-DNA concatemer was constructed for highly efficient capture of MCF-7 cells carrying CdSe@CdS QDs, a sensitive material. The linear range of this proposed signal-on PEC sensing method was 300 cell mL−1 to 6 × 105 cell mL−1 with a detection limit of 3 cell mL−1, and it demonstrated an ultrasensitive response to CTCs. Furthermore, this PEC sensor enabled accurate detection of CTCs in serum samples. Hence, a promising strategy for CTC detection in clinical diagnosis was developed based on CdSe@CdS QD–sensitized Au NP/α-Fe2O3-based PEC cytosensor with dendritic aptamer-DNA concatemer. Graphical abstract
- Open Access
- 24 April 2023
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 13 (19) , 12966-12972
Ultrasensitive electrochemical biosensor for detection of circulating tumor cells based on a highly efficient enzymatic cascade reaction
There has been great interest in the enzymatic cascade amplification strategy for the electrochemical detection of circulating tumor cells (CTCs). In this work, we designed a highly efficient enzymatic cascade reaction based on a multiwalled carbon nanotubes–chitosan (MWCNTs–CS) composite for detection of CTCs. A high electrochemical effective surface area was obtained for a MWCNTs–CS-modified glassy carbon electrode (GCE) for loading glucose oxidase (GOD), as well as a high loading rate and high electrical activity of the enzyme. As a ‘power source’, the MWCNTs–CS composites provided a strong driving power for horseradish peroxidase (HRP) on the surface of polystyrene (PS) microspheres, which acted as probes for capturing CTCs and allowed the reaction to proceed with further facilitation of electron transfer. Aptamer, CTCs, and PS microspheres with HRP and anti-epithelial cell adhesion molecule (anti-EpCAM) antibody were assembled on the MWCNTs–CS/GCE to allow for the modulation of enzyme distance at the micrometer level, and thus ultra-long-range signal transmission was made possible. An ultrasensitive response to CTCs was obtained via this proposed sensing strategy, with a linear range from 10 cell mL−1 to 6 × 106 cell mL−1 and a detection limit of 3 cell mL−1. Moreover, this electrochemical sensor possessed the capability to detect CTCs in serum samples with satisfactory accuracy, which indicated great potential for early diagnosis and clinical analysis of cancer.
- 24 April 2023
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 13 (19) , 12966-12972
Open AccessUltrasensitive electrochemical biosensor for detection of circulating tumor cells based on a highly efficient enzymatic cascade reaction
There has been great interest in the enzymatic cascade amplification strategy for the electrochemical detection of circulating tumor cells (CTCs). In this work, we designed a highly efficient enzymatic cascade reaction based on a multiwalled carbon nanotubes–chitosan (MWCNTs–CS) composite for detection of CTCs. A high electrochemical effective surface area was obtained for a MWCNTs–CS-modified glassy carbon electrode (GCE) for loading glucose oxidase (GOD), as well as a high loading rate and high electrical activity of the enzyme. As a ‘power source’, the MWCNTs–CS composites provided a strong driving power for horseradish peroxidase (HRP) on the surface of polystyrene (PS) microspheres, which acted as probes for capturing CTCs and allowed the reaction to proceed with further facilitation of electron transfer. Aptamer, CTCs, and PS microspheres with HRP and anti-epithelial cell adhesion molecule (anti-EpCAM) antibody were assembled on the MWCNTs–CS/GCE to allow for the modulation of enzyme distance at the micrometer level, and thus ultra-long-range signal transmission was made possible. An ultrasensitive response to CTCs was obtained via this proposed sensing strategy, with a linear range from 10 cell mL−1 to 6 × 106 cell mL−1 and a detection limit of 3 cell mL−1. Moreover, this electrochemical sensor possessed the capability to detect CTCs in serum samples with satisfactory accuracy, which indicated great potential for early diagnosis and clinical analysis of cancer.